ANA 6134 Pancreas Case Study: Type 1 Diabetes and DKA Model Answer Extract
For information and reference only – not to be submitted as your own work.
This is an abridged model-answer extract for the ANA 6134 Anatomy and Physiology 2 pancreas case study: a 19-year-old patient with newly diagnosed type 1 diabetes presenting in diabetic ketoacidosis (DKA). It follows the five questions in the brief and keeps the explanations at first-year nursing level. For a step-by-step planning guide, read our blog on how to approach the pancreas and DKA case study. Values quoted for the patient come from the brief; reference ranges and guideline thresholds come from the sources listed at the end.
How this sample maps to the marks
| Part | Focus | Marks | Target words |
|---|---|---|---|
| Introduction | Case summary and aim of the essay | Within writing mark | 100 |
| 1 | Pancreas anatomy and histology | 15 | 300 |
| 2 | Glucose regulation and negative feedback | 20 | 400 |
| 3 | Pathophysiology of DKA, signs, potassium | 25 | 500 |
| 4 | Laboratory interpretation | 15 | 350 |
| 5 | Physiological rationale for nursing priorities | 10 | 250 |
| Conclusion and referencing | Structure, literature, APA 7th | 15 | 100 |
Introduction
A previously well 19-year-old patient arrived in the Emergency Department after three weeks of thirst, polyuria and weight loss, followed by two days of vomiting and abdominal pain. Blood glucose was 28.6 mmol/L, blood ketones 5.2 mmol/L and venous pH 7.18, with positive anti-GAD antibodies. These findings fit new-onset type 1 diabetes with DKA (Dhatariya et al., 2020). This essay explains the pancreatic anatomy involved, how glucose is normally regulated, why the metabolic crisis developed, how the results are interpreted, and why the nursing priorities follow from the physiology.
1. Anatomy and histology of the pancreas
Location and parts
The pancreas is a soft, elongated retroperitoneal gland, about 12–15 cm long, lying roughly at the L1–L2 level behind the stomach (Standring, 2021). The head sits in the C-shaped curve of the duodenum and includes the hook-like uncinate process. The neck lies in front of the confluence of the superior mesenteric and splenic veins. The body crosses the aorta and the left side of the vertebral column, and the tail runs towards the splenic hilum. Anteriorly lies the stomach, separated by the lesser sac; posteriorly lie the aorta, inferior vena cava, left kidney and the splenic vein.
Duct system
Exocrine secretions drain into the main pancreatic duct, which runs the length of the gland and usually joins the common bile duct at the hepatopancreatic ampulla. This opens into the second part of the duodenum at the major duodenal papilla, controlled by the sphincter of Oddi. A smaller accessory duct often drains the upper head through the minor papilla (Standring, 2021).
Exocrine and endocrine tissue
Most of the gland, about 98%, is exocrine. Clusters of acinar cells secrete digestive enzymes such as amylase, lipase and the inactive proteases trypsinogen and chymotrypsinogen, while duct cells secrete a bicarbonate-rich fluid that neutralises gastric acid. The endocrine part, about 1–2% of the volume, forms around one million islets of Langerhans, scattered mainly through the body and tail (Hall & Hall, 2021). Table 1 summarises the cell types.
| Islet cell | Product | Main action |
|---|---|---|
| Beta | Insulin (with C-peptide and amylin) | Lowers blood glucose; promotes storage |
| Alpha | Glucagon | Raises blood glucose; promotes release of stored fuel |
| Delta | Somatostatin | Local inhibition of insulin and glucagon release |
| PP cells | Pancreatic polypeptide | Modulates exocrine secretion and appetite |
Table 1. Endocrine cells of the islets of Langerhans.
Islet structure and blood supply
Beta cells form the largest population in a human islet, with alpha and delta cells interspersed among them, so hormones act on neighbouring cells within the islet as well as in the circulation (Hall & Hall, 2021). Arterial blood comes from the splenic artery and from the superior and inferior pancreaticoduodenal arteries, branches of the gastroduodenal and superior mesenteric arteries. Each islet has a dense fenestrated capillary network, which lets glucose reach beta cells quickly and lets hormones leave quickly. Venous blood drains to the portal vein, so the liver, the main target of insulin and glucagon, receives the highest hormone concentrations first.
2. Regulation of blood glucose
After a meal
Glucose absorbed from the gut enters beta cells through GLUT2 transporters and is metabolised, raising intracellular ATP. This closes ATP-sensitive potassium channels, depolarises the cell, opens voltage-gated calcium channels and triggers exocytosis of insulin granules. Gut incretin hormones (GLP-1 and GIP) amplify the response (Hall & Hall, 2021). Insulin binds receptors on liver, skeletal muscle and adipose tissue. In muscle and fat it moves GLUT4 transporters to the cell surface, increasing glucose uptake. In the liver it promotes glycogen synthesis and suppresses gluconeogenesis. In adipose tissue it inhibits hormone-sensitive lipase, so fat is stored rather than broken down, and it also promotes protein synthesis. Blood glucose therefore falls back towards the normal fasting range of about 4–6 mmol/L.
During fasting
As glucose falls, insulin secretion drops and alpha cells release glucagon. Glucagon acts mainly on the liver, stimulating glycogenolysis and then gluconeogenesis from amino acids, lactate and glycerol. With prolonged fasting, falling insulin allows lipolysis and a modest rise in ketone production, which supplies fuel to the brain and muscle. Adrenaline, cortisol and growth hormone also oppose insulin when glucose is low or during stress.
Somatostatin and negative feedback
Somatostatin from delta cells acts as a paracrine brake, inhibiting both insulin and glucagon release and slowing nutrient absorption from the gut (Hall & Hall, 2021). Insulin itself also suppresses alpha cell output inside the islet.
Both loops are negative feedback. In the post-meal loop the stimulus is a rise in blood glucose, the sensor is the beta cell, the effector is insulin acting on liver, muscle and fat, and the response is a fall in glucose that switches off the stimulus. In the fasting loop a fall in glucose lowers insulin and raises glucagon, which raises glucose back towards the set range. In type 1 diabetes the first loop has no working sensor-effector link, so glucose rises without a brake.
3. Pathophysiology of DKA
(a) From insulin loss to acidosis
Type 1 diabetes results from autoimmune destruction of beta cells (Atkinson et al., 2014). With almost no insulin, muscle and fat cannot take up glucose and the liver, no longer restrained, produces glucose by glycogenolysis and gluconeogenesis, aided by unopposed glucagon and the stress hormones. The sequence runs as follows.
- Hyperglycaemia. Glucose reached 28.6 mmol/L, far above the renal threshold of about 10 mmol/L.
- Osmotic diuresis. Unreabsorbed glucose in the tubules holds water in the urine, causing polyuria and loss of sodium, potassium, phosphate and water.
- Lipolysis. Without insulin, hormone-sensitive lipase is unrestrained and adipose tissue releases free fatty acids and glycerol.
- Ketogenesis. In liver mitochondria, fatty acids are oxidised to acetyl-CoA faster than the citric acid cycle can use it, and the excess forms acetoacetate and beta-hydroxybutyrate, plus acetone (Dhatariya et al., 2020).
- Metabolic acidosis. Both ketoacids are moderately strong acids; they release hydrogen ions that use up bicarbonate (10 mmol/L) and lower pH (7.18).
- Respiratory compensation. Chemoreceptors detect the acidaemia and drive deep, rapid breathing (Kussmaul respiration), blowing off carbon dioxide. The PaCO2 of 24 mmHg is close to the value predicted for this bicarbonate by Winter’s formula (1.5 × 10 + 8 = 23 mmHg), so the compensation is appropriate.
(b) Linking the signs to mechanisms
| Sign or symptom | Mechanism |
|---|---|
| Polyuria | Osmotic diuresis from glycosuria |
| Polydipsia | Raised plasma osmolality and volume loss stimulate hypothalamic thirst |
| Weight loss | Fluid loss plus catabolism of fat and protein because cells cannot use glucose |
| Fruity breath | Exhaled acetone from ketone metabolism |
| Deep rapid breathing | Respiratory compensation for metabolic acidosis |
| Low BP (96/58 mmHg) | Reduced circulating volume and some acidosis-related vasodilatation |
| Fast heart rate (118/min) | Baroreceptor-driven sympathetic response to hypovolaemia |
| Drowsiness (GCS 14) | Acidosis and raised effective osmolality (about 302 mOsm/kg here) depress neuronal function; poor cerebral perfusion may add |
Table 2. Clinical features and their mechanisms.
(c) Why potassium is high despite total-body depletion
The serum potassium of 5.6 mmol/L reflects redistribution, not stores. Insulin normally stimulates the Na+/K+-ATPase and potassium entry into cells, so insulin deficiency leaves potassium to move out. Hyperosmolality drags water and potassium from cells, acidosis adds to the shift, and falling renal perfusion reduces potassium excretion. Yet the osmotic diuresis, vomiting and secondary aldosterone excess have depleted body stores (Dhatariya et al., 2020). When insulin and fluids are given, potassium re-enters cells and the serum level can fall sharply, so a normal or high starting value must not be taken as reassurance.
4. Interpreting the laboratory results
(a) C-peptide, anti-GAD and HbA1c
Proinsulin is cleaved into insulin and C-peptide in equal amounts, so C-peptide indicates how much insulin the patient’s own beta cells are making. A level of 0.1 nmol/L, in the presence of a glucose of 28.6 mmol/L that should be driving secretion, points to severe beta-cell loss. Positive anti-GAD antibodies show autoimmunity directed at an enzyme in beta cells and support an autoimmune cause rather than a metabolic one (Atkinson et al., 2014; Katsarou et al., 2017). HbA1c of 12.4% (about 112 mmol/mol) reflects average glycaemia over roughly the previous two to three months. It confirms sustained hyperglycaemia but does not itself measure the amount of beta-cell damage.
(b) Comparison with type 2 diabetes
| Feature | Type 1 (this patient) | Type 2 |
|---|---|---|
| Core defect | Autoimmune loss of beta cells; absolute insulin deficiency | Insulin resistance with relative deficiency |
| C-peptide | Low or undetectable | Normal or raised early on |
| Autoantibodies | Usually present (anti-GAD) | Absent |
| Typical onset | Weeks, often younger, lean | Gradual, often older, higher BMI |
| Ketosis | Common, as DKA | Less common; residual insulin restrains lipolysis |
Table 3. Type 1 and type 2 diabetes compared.
(c) Normal lipase and low sodium
Lipase is an exocrine enzyme released from acinar cells. The autoimmune attack in type 1 diabetes targets beta cells, which make up only 1–2% of the gland, so acinar integrity and lipase stay normal. A normal value also makes acute pancreatitis, a recognised cause of abdominal pain, unlikely; the pain here is more likely from ketosis and delayed gastric emptying.
The sodium of 131 mmol/L is low even though water has been lost. Hyperglycaemia raises extracellular osmolality and draws water out of cells, diluting plasma sodium. A common correction adds about 0.3 mmol/L of sodium for each 1 mmol/L of glucose above normal, giving roughly 138 mmol/L here: the true sodium is near normal, and as glucose falls the measured value will rise (Dhatariya et al., 2020).
5. Physiological rationale for nursing priorities
Hourly glucose and ketones. Insulin infusion should lower glucose and ketones at predictable rates; UK guidance targets a ketone fall of at least 0.5 mmol/L per hour and a glucose fall of about 3 mmol/L per hour (Joint British Diabetes Societies for Inpatient Care [JBDS-IP], 2023). Slow change suggests inadequate insulin or fluid, while rapid glucose fall risks hypoglycaemia, because ketone clearance takes longer than glucose clearance. Once glucose drops below about 14 mmol/L, a glucose-containing infusion is added so insulin can continue to switch off ketogenesis.
Potassium and heart rhythm. Insulin drives potassium into cells, so serum levels fall during treatment. Potassium is added to fluids when levels are below about 5.5 mmol/L and checked regularly (JBDS-IP, 2023). Cardiac monitoring detects peaked T waves, flattened T waves, U waves or arrhythmias early, since both hyper- and hypokalaemia alter myocardial excitability.
Fluid balance and vital signs. Intravenous 0.9% sodium chloride restores circulating volume, improves renal perfusion and glomerular filtration so ketones and glucose are cleared, and lowers glucose by dilution. Strict intake and urine output, blood pressure, heart rate and respiratory rate show whether perfusion is recovering and whether fluid overload is developing.
Consciousness level. GCS reflects brain acid-base and osmotic status; a falling score may signal worsening acidosis, cerebral oedema or hypoglycaemia and needs prompt escalation.
Insulin and fluids together. Insulin, usually a fixed-rate infusion of about 0.1 units/kg/hour (about 4.9 units/hour for 49 kg), suppresses lipolysis and ketogenesis and lets the body use glucose; fluids correct the volume deficit. Both are needed to reverse acidosis (Umpierrez et al., 2024).
Conclusion
The patient’s picture follows directly from the loss of beta-cell insulin: unopposed hepatic glucose output, osmotic diuresis, unrestrained lipolysis and ketone-driven acidosis with respiratory compensation. Understanding the anatomy, the two feedback loops and the electrolyte shifts explains why treatment needs combined fluids, insulin, potassium management and close monitoring.
Where to go next
If you are working on a similar clinical case, our nursing assignment helper page explains how we support nursing briefs. Before you submit, our citation and referencing verification service checks APA 7th entries against sources. You can browse other briefs on the MAHSA University questions page, or submit your own assignment for a quote.
References
- Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014). Type 1 diabetes. The Lancet, 383(9911), 69–82. https://doi.org/10.1016/S0140-6736(13)60591-7
- Dhatariya, K. K., Glaser, N. S., Codner, E., & Umpierrez, G. E. (2020). Diabetic ketoacidosis. Nature Reviews Disease Primers, 6, Article 40. https://doi.org/10.1038/s41572-020-0165-1
- Hall, J. E., & Hall, M. E. (2021). Guyton and Hall textbook of medical physiology (14th ed.). Elsevier.
- Joint British Diabetes Societies for Inpatient Care. (2023). The management of diabetic ketoacidosis in adults (3rd ed., updated). Diabetes UK / Association of British Clinical Diabetologists.
- Katsarou, A., Gudbjörnsdottir, S., Rawshani, A., Dabelea, D., Bonifacio, E., Anderson, B. J., Jacobsen, L. M., Schatz, D. A., & Lernmark, Å. (2017). Type 1 diabetes mellitus. Nature Reviews Disease Primers, 3, Article 17016. https://doi.org/10.1038/nrdp.2017.16
- Standring, S. (Ed.). (2021). Gray’s anatomy: The anatomical basis of clinical practice (42nd ed.). Elsevier.
- Umpierrez, G. E., Davis, G. M., ElSayed, N. A., Fadini, G. P., Galindo, R. J., Hirsch, I. B., Klonoff, D. C., McCoy, R. G., Misra, S., Gabbay, R. A., Bannuru, R. R., & Dhatariya, K. K. (2024). Hyperglycemic crises in adults with diabetes: A consensus report. Diabetes Care, 47(8), 1257–1275. https://doi.org/10.2337/dci24-0032
Prepared by
Assignment Helper Editorial Team
This model answer was prepared by our editorial team in response to a real assignment brief we received. It shows one way to approach the task and is meant as a study guide, not for submission.
Need a custom answer for your subject?
Share your module details and get fast, original academic support from our team.